JS

Jasbir Singh

Active Director Director DIN 07171941
DIN 07171941 First appointment Jun 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Jasbir Singh

Data last updated:

Jasbir Singh is a Director at Beatus Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Beatus Pharmaceuticals Private Limited reported revenue of ₹34,982 (FY 2025).

DIN 07171941
Primary Designation Director
Industry Trading
First Appointment 09 Jun 2015
Oldest Company Age 11 yrs
Largest company Beatus Pharmaceuticals Private Limited · ₹34,982 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20152015₹34,982 (FY 2025)Active

Board colleagues of Jasbir Singh

NameDINCompanyDesignation
Manpreet Kaur07171943Beatus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Beatus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jasbir Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jasbir Singh

Jasbir Singh currently holds 1 directorship: Beatus Pharmaceuticals Private Limited (Director, since 09 Jun 2015, revenue ₹34,982 (FY 2025)).

Jasbir Singh was first appointed on 09 Jun 2015 as Director at Beatus Pharmaceuticals Private Limited.

The current boards of Jasbir Singh's companies include Manpreet Kaur (Beatus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available